Efficacy of Conservative Treatments for Urinary Incontinence in Women
ConditionUrinary Incontinence
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age20-100
SponsorMackay Medical College
About this trial
To conduct a retrospective study to examine the effect of these conservative treatments to the symptoms and quality of life of patients with urinary incontinence. The investigators will use both subjective and objective assessment parameters, such as self-report symptoms, bladder diary, pad test and urodynamic study to access the improvement.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult female patient diagnosed with urinary incontinence through clinical assessment
Diagnosed at Mackay Memorial Hospital and underwent non-surgical treatment and subsequent follow-up.
Disqualifiers
Choosing invasive or surgical treatment options (such as bladder botulinum toxin injection, urethral sling surgery).
Unable to comply with regular follow-up for at least one year.
Pregnant women
Patients with a history of neuromuscular disorders.
Trial population
Diagnosed at Mackay Memorial Hospital, the adult female patient was clinically assessed and diagnosed with urinary incontinence. Non-surgical treatments were administered, followed by subsequent monitoring and follow-up.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
BT
Procedure/SurgeryA program of BT (including exercise and muscle training)
bPFMT
Procedure/SurgeryA bPFMT program at home
iVES
Procedure/SurgeryAn iVES program at home
BT + bPFMT
Procedure/SurgeryCombination of BT and bPFMT
BT + iVES
Procedure/SurgeryCombination of BT and iVES
bPFMT + iVES
Procedure/SurgeryCombination of bPFMT and iVES
Treatment groups
60 Participants
are divided into 6 treatment groups6
Treatment groupsSee each treatment group below.
Group A: Bladder training (BT)1 intervention
Group B: biofeedback-assisted pelvic floor muscle training (bPFMT)1 intervention
Group C: intra-vaginal electric stimulation (iVES)1 intervention
Group D: BT+bPFMT1 intervention
Group E: BT+iVES1 intervention
Group F: bPFMT+iVES1 intervention
Trial outcomes
Primary outcomes
1
Urodynamic study (intravesical pressure)
intravesical pressure (cmH2O)
Time frame
form the baseline to the post-treatment measurement (about 6 month post)2
Urodynamic study (abdominal pressure)
abdominal pressure (cmH2O)
Time frame
form the baseline to the post-treatment measurement (about 6 month post)3
Urodynamic study (detrusor pressure)
detrusor pressure (cmH2O)
Time frame
from the baseline to the post-treatment measurement (about 6 month post)4
Urodynamic study (Infused volume)
infused volume (ml)
Time frame
from the baseline to the post-treatment measurement (about 6 month post)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov